MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 31 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $204,000 | +4.6% | 263,370 | +49.4% | 0.00% | – |
| Q2 2020 | $195,000 | +182.6% | 176,340 | +14.0% | 0.00% | – |
| Q1 2020 | $69,000 | -53.4% | 154,719 | -50.0% | 0.00% | – |
| Q4 2019 | $148,000 | +31.0% | 309,438 | +100.0% | 0.00% | – |
| Q3 2019 | $113,000 | -64.6% | 154,719 | -0.7% | 0.00% | – |
| Q2 2019 | $319,000 | -52.6% | 155,860 | -35.4% | 0.00% | – |
| Q1 2019 | $673,000 | -51.7% | 241,264 | -47.6% | 0.00% | – |
| Q4 2018 | $1,394,000 | +14.4% | 460,254 | +110.6% | 0.00% | – |
| Q3 2018 | $1,219,000 | -9.0% | 218,586 | +4.5% | 0.00% | – |
| Q2 2018 | $1,340,000 | +88.2% | 209,119 | +105.8% | 0.00% | – |
| Q1 2018 | $712,000 | -26.1% | 101,627 | +9.9% | 0.00% | – |
| Q4 2017 | $964,000 | +24.9% | 92,482 | +9.6% | 0.00% | – |
| Q3 2017 | $772,000 | +94.0% | 84,402 | +173.8% | 0.00% | – |
| Q2 2017 | $398,000 | +168.9% | 30,826 | +157.8% | 0.00% | – |
| Q1 2017 | $148,000 | – | 11,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,142,580 | $6,442,000 | 2.67% |
| 683 Capital Management, LLC | 1,766,038 | $3,620,000 | 0.33% |
| BIEGEL & WALLER LLC | 66,508 | $136,000 | 0.07% |
| Motley Fool Asset Management LLC | 176,874 | $363,000 | 0.04% |
| Aveo Capital Partners, LLC | 16,732 | $35,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 12,891 | $26,426,000 | 0.01% |
| Paloma Partners Management Co | 116,700 | $239,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 594,956 | $1,220,000 | 0.00% |
| A.R.T. Advisors, LLC | 13,703 | $28,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,682 | $22,000 | 0.00% |